QOL OUTCOMES DURING LONG-TERM TREATMENT WITH DARIFENACIN FOR OVERACTIVE BLADDER (OAB): A 2-YEAR, OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Young, Jay [1 ]
Lheritier, Karine [2 ]
Steel, Michael [3 ]
Dwyer, Peter [4 ]
机构：
[1] Orange Cty Urol Associates, Med Res Ctr, Laguna Woods, CA USA
[2] Novartis Pharma AG, Biostat, Basel, Switzerland
[3] Novartis Pharma AG, Clin Dev & Med Affairs, Basel, Switzerland
[4] Mercy Hosp Women, Urogynaecol, Melbourne, Vic, Australia
来源：
QUALITY OF LIFE RESEARCH | 2005年 / 14卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
P-36/1678
引用
收藏
页码：2036 / 2036
页数：1
相关论文
共 50 条
  • [31] Long-term treatment with ganaxolone for seizures associated with CDKL5 Deficiency Disorder: 2-year open-label extension follow-up
    Miller, I
    Demarest, S.
    Bahi-Buisson, N.
    Pestana-Knight, E.
    Devinsky, O.
    Amin, S.
    Marsh, E.
    Aimetti, A.
    Hulihan, J.
    Olson, H.
    ANNALS OF NEUROLOGY, 2023, 94 : S63 - S63
  • [32] Safety and effectiveness of long-term treatment with lurasidone in children and adolescents with bipolar depression: A 6-month interim analysis of a 2-year open-label extension study
    Chang, K.
    Tocco, M.
    Goldman, R.
    Pikalov, A.
    Deng, L.
    Cucchiaro, J.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2018, 48 : S81 - S82
  • [33] LONG-TERM SPARSENTAN TREATMENT IN FSGS IN THE DUET OPEN-LABEL EXTENSION (OLE)
    Trachtman, Howard
    Srivastava, Tarak
    Tesar, Vladimir
    Campbell, Kirk N.
    Rheault, Michelle N.
    Komers, Radko
    Murphy, Edward
    Prasad, Andy
    Gesualdo, Loreto
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2023, 81 (04) : S99 - S99
  • [34] Long-Term Results from an Open-Label Extension Study of Atacicept for the Treatment of IgA Nephropathy
    Barratt, Jonathan
    Barbour, Sean
    Brenner, Robert
    Cooper, Kerry
    Wei, Xuelian
    Eren, Necmi
    Floege, Juergen
    Jha, Vivekanand
    Kim, Sung Gyun
    Maes, Bart
    Phoon, Richard K. S.
    Singh, Harmeet
    Tesar, Vladimir
    Lafayette, Richard
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2024,
  • [35] LONG TERM STUDY OF PREGABALIN FOR THE TREATMENT OF GENERALIZED ANXIETY DISORDER: A 1 YEAR OPEN-LABEL EXTENSION
    Montgomery, S.
    Prieto, R.
    Emir, B.
    Haswell, H.
    EUROPEAN PSYCHIATRY, 2012, 27
  • [36] Long-Term Efficacy and Safety of Inotersen for Hereditary Transthyretin Amyloidosis: NEURO-TTR Open-Label Extension 2-Year Update
    Brannagan, Thomas
    Cruz, Marcia Waddington
    Wang, Annabel K.
    Polydefkis, Michael J.
    Dyck, Peter J.
    Khella, Sami
    Plante-Bordeneuve, Violaine
    Berk, John L.
    Barroso, Fabio
    Merlini, Giampaolo
    Conceicao, Isabel
    Hughes, Steven G.
    Kwoh, Jesse
    Jung, Shiangtung W.
    Guthrie, Spencer
    Pollock, Michael
    Benson, Merrill D.
    Gertz, Morie
    Coelho, Teresa
    NEUROLOGY, 2019, 92 (15)
  • [37] Long-Term efficacy and safety of inotersen for hereditary transthyretin amyloidosis: 2-year results from the NEURO-TTR open-label extension study
    Brannagan, T.
    Waddington Cruz, M.
    Wang, A. K.
    Polydefkis, M. J.
    Dyck, P. J.
    Khella, S.
    Plante-Bordeneuve, V.
    Berk, J. L.
    Barroso, F.
    Merlini, G.
    Conceicao, I.
    Hughes, S. G.
    Kwoh, J.
    Jung, S. W.
    Guthrie, S.
    Pollock, M.
    Benson, M. D.
    Gertz, M.
    Coelho, T.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 92 - 92
  • [38] A long-term, open-label extension study to investigate the long-term safety of alogliptin in subjects with type 2 diabetes
    Smith, N.
    Pratley, R.
    Wilson, C.
    Mekki, Q.
    DIABETOLOGIA, 2017, 60 : S357 - S358
  • [39] LONG-TERM SAFETY AND EFFICACY OF SER120 1.5 MCG IN PATIENTS WITH NOCTURIA: RESULTS FROM A 2-YEAR OPEN-LABEL EXTENSION STUDY
    MacDiarmid, Scott
    Nicandro, J. P.
    Cheng, Maria
    Abrams, Steven
    Fein, Seymour
    Wein, Alan
    JOURNAL OF UROLOGY, 2017, 197 (04): : E398 - E398
  • [40] Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-Label Extension Study
    Fernandez, Hubert H.
    Stamler, David
    Davis, Mat D.
    Factor, Stewart A.
    Hauser, Robert A.
    Jimenez-Shahed, Joohi
    Ondo, William G.
    Jarskog, L. Fredrik
    Woods, Scott W.
    LeDoux, Mark S.
    Shprecher, David R.
    Anderson, Karen E.
    NEUROLOGY, 2018, 90
12345